Multichange Isothermal Mutagenesis: A New Strategy for Multiple Site-Directed Mutations in Plasmid DNA

Department of Molecular Biology and Genetics and High Throughput Biology Center and ‡Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
ACS Synthetic Biology (Impact Factor: 4.98). 03/2013; 2(8). DOI: 10.1021/sb300131w
Source: PubMed


Multichange ISOthermal (MISO) mutagenesis is a new technique allowing simultaneous introduction of multiple site-directed mutations into plasmid DNA by leveraging two existing ideas: QuikChange-style primers and one-step isothermal (ISO) assembly. Inversely partnering pairs of QuikChange primers results in robust, exponential amplification of linear fragments of DNA encoding mutagenic yet homologous ends. These products are amenable to ISO assembly, which efficiently assembles them into a circular, mutagenized plasmid. Because the technique relies on ISO assembly, MISO mutagenesis is additionally amenable to other relevant DNA modifications such as insertions and deletions. Here we provide a detailed description of the MISO mutagenesis concept and highlight its versatility by applying it to three experiments currently intractable with standard site-directed mutagenesis approaches. MISO mutagenesis has the potential to become widely used for site-directed mutagenesis.


Available from: Lixin Dai, Dec 15, 2013
  • Source
    • "The plasmids were constructed with protocols described previously (Mitchell et al. 2013). In this study, the TOP10 strain of E. coli [F– mcrAD(mrrhsdRMS-mcrBC ) F80lacZDM15 DlacX74 recA1 araD139 D(araleu) 7697 galUgalKrpsL (StrR) endA1 nupG] was used for the construction and amplification of plasmids. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Here we describe the engineering of a distant homolog of the Tet repressor, CamR, isolated from Pseudomonas putida, that is regulated by camphor, a very inexpensive small molecule, at micromolar concentrations, for use in Saccharomyces cerevisiae. The repressor was engineered by expression from a constitutive yeast promoter, fusion to a viral activator protein cassette, and codon optimization. A suitable promoter responsive to the CamR fusion protein was engineered by embedding a P. putida operator binding sequence within an upstream activating sequence (UAS)-less CYC1 promoter from S. cerevisiae. The switch, named the Camphor-Off switch, activates expression of a reporter gene in camphor-free media and represses it with micromolar concentrations of camphor. Copyright © 2015 Author et al.
    G3-Genes Genomes Genetics 07/2015; 5(10). DOI:10.1534/g3.114.012765 · 3.20 Impact Factor
  • Source
    • "Since 1990, several homologous DNA assembly methods [16-21] have been developed; one method in particular, one-step isothermal in vitro recombination (the ISO method) [20], was used to introduce multiple site-directed mutations [22]. In this method, termed as multichange isothermal in vitro recombination (the MISO method), multiple DNA fragments were first prepared using polymerase chain reaction (PCR) followed by gel purification. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Various DNA manipulation methods have been developed to prepare mutant genes for protein engineering. However, development of more efficient and convenient method is still demanded. Homologous DNA assembly methods, which do not depend on restriction enzymes, have been used as convenient tools for cloning and have been applied to site-directed mutagenesis recently. This study describes an optimized homologous DNA assembly method, termed as multiple patch cloning (MUPAC), for multiple site-directed and saturation mutagenesis. To demonstrate MUPAC, we introduced five back mutations to a mutant green fluorescent protein (GFPuv) with five deleterious mutations at specific sites and transformed Escherichia coli (E. coli) with the plasmids obtained. We observed that the over 90% of resulting colonies possessed the plasmids containing the reverted GFPuv gene and exhibited fluorescence. We extended the test to introduce up to nine mutations in Moloney Murine Leukemia Virus reverse transcriptase (M-MLV RT) by assembling 11 DNA fragments using MUPAC. Analysis of the cloned plasmid by electrophoresis and DNA sequencing revealed that approximately 30% of colonies had the objective mutant M-MLV RT gene. Furthermore, we also utilized this method to prepare a library of mutant GFPuv genes containing saturation mutations at five specific sites, and we found that MUPAC successfully introduced NNK codons at all five sites, whereas other site remained intact. MUPAC could efficiently introduce various mutations at multiple specific sites within a gene. Furthermore, it could facilitate the preparation of experimental gene materials important to molecular and synthetic biology research.
    BMC Biotechnology 10/2013; 13(1):91. DOI:10.1186/1472-6750-13-91 · 2.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Engineering complex biological systems typically requires combinatorial optimization to achieve the desired functionality. Here, we present Multiplex Iterative Plasmid Engineering (MIPE), which is a highly efficient and customized method for combinatorial diversification of plasmid sequences. MIPE exploits ssDNA mediated λ Red recombineering for the introduction of mutations, allowing it to target several sites simultaneously and generate libraries of up to 10 (7) sequences in one reaction. We also describe "restriction digestion mediated co-selection (RD CoS)", which enables MIPE to produce enhanced recombineering efficiencies with greatly simplified coselection procedures. To demonstrate this approach, we applied MIPE to fine-tune gene expression level in the 5-gene riboflavin biosynthetic pathway and successfully isolated a clone with 2.67-fold improved production in less than a week. We further demonstrated the ability of MIPE for highly multiplexed diversification of protein coding sequence by simultaneously targeting 23 codons scattered along the 750 bp sequence. We anticipate this method to benefit the optimization of diverse biological systems in synthetic biology and metabolic engineering.
    ACS Synthetic Biology 09/2013; DOI:10.1021/sb400051t · 4.98 Impact Factor
Show more